US Stock MarketDetailed Quotes

MRSN Mersana Therapeutics

Watchlist
  • 0.380
  • +0.007+1.96%
Close Mar 28 16:00 ET
  • 0.389
  • +0.009+2.45%
Post 19:46 ET
47.30MMarket Cap-0.68P/E (TTM)

Mersana Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
51.24%-82.34M
39.77%-19.25M
81.39%-8.58M
64.66%-21.86M
-12.59%-32.66M
-242.12%-168.88M
37.61%-31.96M
-184.40%-46.08M
-38.10%-61.83M
-264.61%-29.01M
Net income from continuing operations
59.69%-69.19M
27.77%-14.12M
72.39%-11.5M
55.31%-24.27M
65.63%-19.31M
15.94%-171.67M
56.50%-19.54M
30.35%-41.66M
-4.00%-54.31M
-18.84%-56.16M
Depreciation and amortization
7.32%1.63M
-10.51%400K
-5.85%402K
24.38%403K
32.60%423K
63.65%1.52M
58.51%447K
100.47%427K
42.73%324K
55.61%319K
Other non cash items
-1.33%3.42M
1.02%889K
-6.17%867K
0.95%850K
-0.73%815K
-2.06%3.47M
-70.33%880K
378.76%924K
350.27%842K
323.20%821K
Change In working capital
-63.82%-30.74M
47.50%-9.19M
83.51%-1.44M
85.39%-1.98M
-186.25%-18.13M
-114.40%-18.76M
-26.80%-17.5M
-108.01%-8.73M
-859.44%-13.56M
-37.10%21.02M
-Change in receivables
--0
--1M
--570K
---1.57M
--0
200.00%30M
--0
--0
--0
--30M
-Change in prepaid assets
-23.91%2.69M
-44.31%2.1M
-84.90%264K
90.08%-259K
-6.45%580K
-8.52%3.53M
169.09%3.78M
-14.31%1.75M
-396.48%-2.61M
234.20%620K
-Change in payables and accrued expense
78.56%-5.79M
120.68%2.63M
98.34%-135K
438.87%1.92M
-82.32%-10.21M
-285.79%-27.02M
-927.21%-12.74M
-164.99%-8.11M
-110.88%-566K
-19.56%-5.6M
-Change in other current assets
---500K
--0
--0
----
----
--0
--0
--0
----
----
-Change in other current liabilities
-3.53%-3.25M
-37.83%-1.32M
40.00%-459K
-16.85%-846K
9.61%-630K
-75.49%-3.14M
-1,467.14%-957K
-15.56%-765K
-16.77%-724K
-20.38%-697K
-Change in other working capital
-7.87%-23.88M
-79.45%-13.61M
-4.87%-1.68M
92.51%-723K
-138.46%-7.87M
-115.41%-22.14M
-149.52%-7.58M
-101.70%-1.6M
-125.35%-9.65M
-108.63%-3.3M
Cash from discontinued investing activities
Operating cash flow
51.24%-82.34M
39.77%-19.25M
81.39%-8.58M
64.66%-21.86M
-12.59%-32.66M
-242.12%-168.88M
37.61%-31.96M
-184.40%-46.08M
-38.10%-61.83M
-264.61%-29.01M
Investing cash flow
Cash flow from continuing investing activities
-90.46%11.44M
148.16%50M
-72.57%28.47M
201.38%5.51M
-5,296.78%-72.55M
178.50%119.88M
144.35%20.15M
729.30%103.78M
93.99%-5.44M
524.32%1.4M
Net PPE purchase and sale
93.91%-132K
--0
--0
--0
85.51%-132K
1.32%-2.17M
50.83%-386K
-10.80%-472K
39.27%-399K
-176.90%-911K
Net investment purchase and sale
-90.52%11.57M
143.50%50M
-72.69%28.47M
209.40%5.51M
-3,238.93%-72.42M
181.09%122.05M
146.00%20.53M
748.93%104.25M
94.39%-5.04M
--2.31M
Cash from discontinued investing activities
Investing cash flow
-90.46%11.44M
148.16%50M
-72.57%28.47M
201.38%5.51M
-5,296.78%-72.55M
178.50%119.88M
144.35%20.15M
729.30%103.78M
93.99%-5.44M
524.32%1.4M
Financing cash flow
Cash flow from continuing financing activities
-95.68%4.09M
-2,129.35%-1.87M
84.25%-23K
-99.79%153K
-72.95%5.83M
-38.13%94.68M
-99.78%92K
-101.37%-146K
80.57%73.18M
-64.32%21.55M
Net issuance payments of debt
-441.26%-2.23M
-869.91%-2.1M
64.62%-23K
28.79%-47K
0.00%-65K
-51.47%-412K
-232.31%-216K
0.00%-65K
0.00%-66K
14.47%-65K
Net common stock issuance
-93.82%5.78M
--0
--0
-100.09%-66K
-73.10%5.85M
-38.01%93.54M
--0
-100.76%-81K
79.78%71.89M
-64.01%21.73M
Proceeds from stock option exercised by employees
-64.99%542K
44.30%228K
--0
-80.38%266K
41.18%48K
-35.39%1.55M
-90.03%158K
--0
123.76%1.36M
-64.58%34K
Net other financing activities
----
----
----
----
----
----
----
--0
--0
---150K
Cash from discontinued financing activities
Financing cash flow
-95.68%4.09M
-2,129.35%-1.87M
84.25%-23K
-99.79%153K
-72.95%5.83M
-38.13%94.68M
-99.78%92K
-101.37%-146K
80.57%73.18M
-64.32%21.55M
Net cash flow
Beginning cash position
35.31%175.04M
-57.51%79.35M
-53.97%59.48M
-38.64%75.66M
35.31%175.04M
-27.50%129.36M
1.19%186.76M
-4.86%129.21M
-46.51%123.3M
-27.50%129.36M
Current changes in cash
-246.27%-66.81M
346.39%28.88M
-65.47%19.87M
-374.05%-16.19M
-1,539.85%-99.38M
193.10%45.68M
78.76%-11.72M
18.07%57.55M
106.24%5.91M
-111.63%-6.06M
End cash Position
-38.17%108.23M
-38.17%108.23M
-57.51%79.35M
-53.97%59.48M
-38.64%75.66M
35.31%175.04M
35.31%175.04M
1.19%186.76M
-4.86%129.21M
-46.51%123.3M
Free cash flow
51.78%-82.47M
40.49%-19.25M
81.58%-8.58M
64.88%-21.86M
-9.60%-32.79M
-231.75%-171.05M
37.81%-32.35M
-185.94%-46.55M
-36.98%-62.23M
-261.13%-29.92M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 51.24%-82.34M39.77%-19.25M81.39%-8.58M64.66%-21.86M-12.59%-32.66M-242.12%-168.88M37.61%-31.96M-184.40%-46.08M-38.10%-61.83M-264.61%-29.01M
Net income from continuing operations 59.69%-69.19M27.77%-14.12M72.39%-11.5M55.31%-24.27M65.63%-19.31M15.94%-171.67M56.50%-19.54M30.35%-41.66M-4.00%-54.31M-18.84%-56.16M
Depreciation and amortization 7.32%1.63M-10.51%400K-5.85%402K24.38%403K32.60%423K63.65%1.52M58.51%447K100.47%427K42.73%324K55.61%319K
Other non cash items -1.33%3.42M1.02%889K-6.17%867K0.95%850K-0.73%815K-2.06%3.47M-70.33%880K378.76%924K350.27%842K323.20%821K
Change In working capital -63.82%-30.74M47.50%-9.19M83.51%-1.44M85.39%-1.98M-186.25%-18.13M-114.40%-18.76M-26.80%-17.5M-108.01%-8.73M-859.44%-13.56M-37.10%21.02M
-Change in receivables --0--1M--570K---1.57M--0200.00%30M--0--0--0--30M
-Change in prepaid assets -23.91%2.69M-44.31%2.1M-84.90%264K90.08%-259K-6.45%580K-8.52%3.53M169.09%3.78M-14.31%1.75M-396.48%-2.61M234.20%620K
-Change in payables and accrued expense 78.56%-5.79M120.68%2.63M98.34%-135K438.87%1.92M-82.32%-10.21M-285.79%-27.02M-927.21%-12.74M-164.99%-8.11M-110.88%-566K-19.56%-5.6M
-Change in other current assets ---500K--0--0----------0--0--0--------
-Change in other current liabilities -3.53%-3.25M-37.83%-1.32M40.00%-459K-16.85%-846K9.61%-630K-75.49%-3.14M-1,467.14%-957K-15.56%-765K-16.77%-724K-20.38%-697K
-Change in other working capital -7.87%-23.88M-79.45%-13.61M-4.87%-1.68M92.51%-723K-138.46%-7.87M-115.41%-22.14M-149.52%-7.58M-101.70%-1.6M-125.35%-9.65M-108.63%-3.3M
Cash from discontinued investing activities
Operating cash flow 51.24%-82.34M39.77%-19.25M81.39%-8.58M64.66%-21.86M-12.59%-32.66M-242.12%-168.88M37.61%-31.96M-184.40%-46.08M-38.10%-61.83M-264.61%-29.01M
Investing cash flow
Cash flow from continuing investing activities -90.46%11.44M148.16%50M-72.57%28.47M201.38%5.51M-5,296.78%-72.55M178.50%119.88M144.35%20.15M729.30%103.78M93.99%-5.44M524.32%1.4M
Net PPE purchase and sale 93.91%-132K--0--0--085.51%-132K1.32%-2.17M50.83%-386K-10.80%-472K39.27%-399K-176.90%-911K
Net investment purchase and sale -90.52%11.57M143.50%50M-72.69%28.47M209.40%5.51M-3,238.93%-72.42M181.09%122.05M146.00%20.53M748.93%104.25M94.39%-5.04M--2.31M
Cash from discontinued investing activities
Investing cash flow -90.46%11.44M148.16%50M-72.57%28.47M201.38%5.51M-5,296.78%-72.55M178.50%119.88M144.35%20.15M729.30%103.78M93.99%-5.44M524.32%1.4M
Financing cash flow
Cash flow from continuing financing activities -95.68%4.09M-2,129.35%-1.87M84.25%-23K-99.79%153K-72.95%5.83M-38.13%94.68M-99.78%92K-101.37%-146K80.57%73.18M-64.32%21.55M
Net issuance payments of debt -441.26%-2.23M-869.91%-2.1M64.62%-23K28.79%-47K0.00%-65K-51.47%-412K-232.31%-216K0.00%-65K0.00%-66K14.47%-65K
Net common stock issuance -93.82%5.78M--0--0-100.09%-66K-73.10%5.85M-38.01%93.54M--0-100.76%-81K79.78%71.89M-64.01%21.73M
Proceeds from stock option exercised by employees -64.99%542K44.30%228K--0-80.38%266K41.18%48K-35.39%1.55M-90.03%158K--0123.76%1.36M-64.58%34K
Net other financing activities ------------------------------0--0---150K
Cash from discontinued financing activities
Financing cash flow -95.68%4.09M-2,129.35%-1.87M84.25%-23K-99.79%153K-72.95%5.83M-38.13%94.68M-99.78%92K-101.37%-146K80.57%73.18M-64.32%21.55M
Net cash flow
Beginning cash position 35.31%175.04M-57.51%79.35M-53.97%59.48M-38.64%75.66M35.31%175.04M-27.50%129.36M1.19%186.76M-4.86%129.21M-46.51%123.3M-27.50%129.36M
Current changes in cash -246.27%-66.81M346.39%28.88M-65.47%19.87M-374.05%-16.19M-1,539.85%-99.38M193.10%45.68M78.76%-11.72M18.07%57.55M106.24%5.91M-111.63%-6.06M
End cash Position -38.17%108.23M-38.17%108.23M-57.51%79.35M-53.97%59.48M-38.64%75.66M35.31%175.04M35.31%175.04M1.19%186.76M-4.86%129.21M-46.51%123.3M
Free cash flow 51.78%-82.47M40.49%-19.25M81.58%-8.58M64.88%-21.86M-9.60%-32.79M-231.75%-171.05M37.81%-32.35M-185.94%-46.55M-36.98%-62.23M-261.13%-29.92M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--------
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Petroleo Brasileiro SA Petrobras
PBR
-0.07%
Vale SA
VALE
-1.28%
NVIDIA
NVDA
-1.58%
Ecopetrol
EC
-1.64%
Taylor Morrison Home
TMHC
-2.11%

Unlock the Full List